G1 Therapeutics Inc To Present New Clinical Data Across Pipeline At European Society For Medical Oncology (ESMO) Transcript
All right. Thank you, everyone. I think we can get started. My name is Jeff Macdonald. I'm the Head of Investor Relations at G1. Thank you all for joining us today here in Barcelona or via webcast. Our team today will discuss data from the ESMO conference as well as longer-range development and commercial strategy. We're very pleased to be joined by Dr. Lisa Carey from The University of North Carolina, leading breast care expert. She'll be providing her perspective on the current state and the future direction of breast care -- excuse me, breast cancer treatment. For those of you who are looking at the webcast, her bio is available in the back of the deck. A few housekeeping items before we start. There'll be 2 Q&A sections, 1 after the clinical data and Dr. Carey's section and then after -- and then again a second Q&A after Dr. Malik and Mr. Demaree go through their development and commercial plans. For those of you who are on the webcast, you are able to ask questions remotely, and we'll plug you in. Or
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
